BetterInvesting™ Magazine Update on Amphastar Pharmaceuticals Inc. and Medtronic PLC
Amphastar Pharmaceuticals, Inc. (AMPH)
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.amphastar.com/investor-relations
Company Research
Source: PR Newswire
TROY, Mich., June 14, 2024 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Amphastar Pharmaceuticals Inc. (NASDAQ: AMPH) as its "Stock to Study" and Medtronic PLC (NYSE: MDT) as its "Undervalued Stock" in the September 2024 issue for investors' informational and educational use."With GameStop back in the headlines, the siren song of easy money has returned, luring the unschooled down treacherous paths. The National Association of Investors counsels everyday Americans seeking long term wealth to focus on fundamentals and learn to earn," said Ken Zendel, CEO of National Association of Investors Corp. (NAIC), the parent organization of BetterInvesting.For a refresher on GameStop vs. the fundamentals, read:https://www.betterinvesting.org/learn-about-investing/investor-education/investing/market-madness-short-selling-short-squeezeCheck the September 2024 issue of BetterInvesting Magazine for more details about the latest st
Show less
Read more
Impact Snapshot
Event Time:
AMPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMPH alerts
High impacting Amphastar Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
AMPH
News
- Organon downgraded, Amneal upgraded as J.P. Morgan reviews specialty pharma Sep. 06, 2024 8:39 AM ET By: Dulan Lokuwithana , SA News Editor [Seeking Alpha]Seeking Alpha
- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare ConferenceAccesswire
- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
AMPH
Earnings
- 8/7/24 - Beat
AMPH
Sec Filings
- 9/6/24 - Form 4
- 9/5/24 - Form 144
- 8/30/24 - Form 8-K
- AMPH's page on the SEC website